Laboratorios Aspen is proud to introduce its new product Sobunir® (Ambrisentan), a pulmonary arterial antihypertensive, which joins the “Pneumonology” division.
Indications:
It is indicated for the control of pulmonary arterial hypertension.
Presentation:
Package containing 5 mg and 10 mg coated tablets.